Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ALB
Deeply overvalued
ALBEMARLE CORP
Price$102.10
Model IV$57.88
P/IV1.90
Premium +76%
Return to IV: -43.3%
Market implies +13.7%/yr
vs model +7.0% · above model
ASIX
Fairly valued
AdvanSix Inc.
Price$16.70
Model IV$16.49
P/IV1.01
Premium +1%
Return to IV: -1.3%
Market implies +1.5%/yr
vs model +2.8% · in line
AVNT
Deeply overvalued
AVIENT CORP
Price$40.98
Model IV$19.19
P/IV2.15
Premium +114%
Return to IV: -53.2%
Market implies +13.5%/yr
vs model +3.4% · above model
DD
Valuation N/A
DuPont de Nemours, Inc.
Price$132.48
Model IV—
P/IV—
Market implies +38.5%/yr
vs model +0.0% · above model
DOW
Undervalued
DOW INC.
Price$28.59
Model IV$37.03
P/IV0.76
Discount 23%
Return to IV: +29.5%
Market implies -3.0%/yr
vs model +1.2% · below model
EMN
Overvalued
EASTMAN CHEMICAL CO
Price$63.76
Model IV$51.99
P/IV1.46
Premium +23%
Return to IV: -18.5%
Market implies +1.2%/yr
vs model +0.0% · in line
HXL
Deeply overvalued
HEXCEL CORP /DE/
Price$85.13
Model IV$33.52
P/IV2.68
Premium +154%
Return to IV: -60.6%
Market implies +19.2%/yr
vs model +8.0% · above model
PCT
Valuation N/A
PureCycle Technologies, Inc.
Price$3.93
Model IV—
P/IV—
Market implies +63.4%/yr
vs model +5.0% · above model
PCTTU
Valuation N/A
PureCycle Technologies, Inc.
Price$4.37
Model IV—
P/IV—
Market implies +57.9%/yr
vs model +5.0% · above model
PCTTW
Valuation N/A
PureCycle Technologies, Inc.
Price$0.56
Model IV—
P/IV—
Market implies +28.9%/yr
vs model +5.0% · above model
ROG
Deeply overvalued
ROGERS CORP
Price$148.12
Model IV$34.32
P/IV4.12
Premium +332%
Return to IV: -76.8%
Market implies +18.9%/yr
vs model +0.0% · above model